1 min read|56 words
Fresenius Kabi has issued a software correction for Ivenix infusion pumps after detecting a battery-display anomaly that may provide inaccurate power-status information to clinical staff. The FDA recommends affected pumps remain continuously connected to mains power until the corrective software is installed. Healthcare facilities should contact the manufacturer immediately.
Read the full article on GMJ Newsroom →
Was this article helpful?

